ANTI-TUMOR POTENTIAL OF ERVATAMIA DIVARICATA. L. BURKILL AGAINST EHRLICH ASCITES CARCINOMA
Keywords:
Ervatamia divaricata, Ehrlich ascites carcinoma, In vitro, In silicoAbstract
Objective: The present study aims to evaluate the anti-tumor potential of EEED (ethanolic extract of Ervatamia divaricata. L. Burkill) on EAC (Ehrlich ascites carcinoma).
Methods: The ethanolic extract of Ervatamia divaricata. L. Burkill was subjected to preliminary phytochemical screening and the antitumor effect of EEED was assessed by employing in-vitro methods. Compounds present in the ethanol extract of the plant were identified using GC-MS (Gas chromatography-mass spectrometry) and attempts were made to understand the mechanism of action using insilico methods.
Results: The results of the in vitro cytotoxicity assay and MTT assay revealed the anticancer potential of the ethanol extract of Ervatamia divaricata. When different concentrations of EEED were assayed, the dead cells were found to increase with increase in concentration of the extract. This proved that there was considerable damage of the cell membrane that leads to the blocking of the cell signaling in cancer cells.
Conclusion: The present study revealed that EEED possessed significant antitumor activity against EAC.
Downloads
References
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC. Lyon, France; 2013.
Tan G, Gyllenhaal C, Soejarto DD. Biodiversity as a source of anticancer drugs. Curr Drug Targets 2006;7:265−77.
John De Britto A, Steena Roshan Sebastian. Biosynthesis of silver nano particles and its antibacterial activity against human pathogens. Int J Pharm Pharm Sci 2013;5(1):257-9.
Wasana Pratchayasakul, Anchalee Pongchaidecha, Nipon Chattipakorn, Siriporn Chattipakorn. Ethnobotany & ethnopharmacology of Tabernaemontana divaricata. Indian J Med Res 2008;127:317-35.
Giwa OE, Seyifunmi OE, Adewumi BL, Adebote VT, Aladejimokun AO. Screening of antimicrobial ethanolic extract of Peristrophe bicalyculata. Ethnobot Leaflets 2010;14:766-73.
Mehmet Ozaslan, Isik Didem Karagoz, Ibrahim Halil Kilic, Muhammed Emim Guldur. Ehrlich ascites carcinoma. Afr J Biotechnol 2011;10(13):2375-8.
Gothoskar SV, Ranadive KJ. Anticancer screening of SAN-AB. An extract of marking nut Semicarpus anacardium. Indian J Exp Biol 1971;9:372-5.
Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001;21:A.3B.1–A.3B.2.
Scudiero DA, Shoemaker RH, Paul KD. Evaluation of soluble terazolium formazan assay for cell growth and drug sensitivity in clusters using human and other tumor cell lines. Cancer Res 1988;48:4827-33.
Sarita Saraswati, Pawan K Kanaujia, Shakti Kumar, Ranjeet Kumar, Abdulqader A Alhaider. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2–mediated angiogenesis. Mol Cancer 2013;12:82.
Eichhorn ME, Kleespies A, Angele MK, Jauch KW, Bruns CJ. Angiogenesis in cancer: molecular mechanisms, clinical impact. Langenbeck's Archives of Surgery 2007;392:371–9.
Srinithya B, Meenakshi Sundaram Muthuraman. An overview on the biological perspectives of sida cordifolia linn. Int J Pharm Pharm Sci 2014;6(11):15-7.
Mallikarjuna G, Jaya Sankar Reddy V, Prabhakaran. Evaluation of anticancer activity of sida cordifolia l. against aflatoxin b1 induced hepatocellular carcinoma. Int J Pharm Sci Rev Res 2013;23(2):126-32.
Baby Joseph, Ajisha AU, Satheesna Kumari, Sujatha S. Effect of bioactive compounds and its pharmaceutical activities of sida cordifolia (Linn.). Int J Biol Med Res 2011;2(4):1038-42.